Clinical Trial Demonstrates Accurate Non-Invasive Detection of In Vivo Biologic Activity in Melanomas by the Orlucent® Skin Fluorescent Imaging System

LOS GATOS, Calif., Jan. 20, 2026 /PRNewswire/ -- In the pivotal clinical trial of their technology, researchers at Orlucent®, Inc. have confirmed the accuracy of the company's Skin Fluorescent Imaging (SFI) System, a non-invasive, hand-held molecular imaging device for the direct,...